J&J will spin-off its consumer healthcare division - here are the details in full.
Haleon share price fell this week after concerns grew around legal proceedings relating to Zantac
Valneva share price has been affected by various contracts losses - Can it bounce back?
GlaxoSmithKline's spin-off Haleon will have its primary listing on the London Stock Exchange
Pfizer plans to sell its GlaxoSmithKline (GSK) spin-off stocks in November
We look at some expectations for Pfizer’s share price performance in 2022.
As Tech sells off, the US healthcare sector is expected to gain S&P 500 weighting
The company may have arrived too late to the party as the UK cuts its spending on Covid-related healthcare
As the world recovers from the effects of Covid-19, what does the future of pharmaceutical stocks look like?
With spotlight back on the healthcare sector, analysts picks some smouldering stocks
The healthcare industry has had disappointing returns in the past year due to upheavals, yet the long-term outlook remains strong.
Other bankruptcy bidders buy Teligent’s plant and drug applications
Scandal-hit Credit Suisse sacks their CEO three months after an all-new review
Vaccine-maker acquires Arena Pharmaceuticals, shares rise
Vaccine announcement curbs Wall Street’s Omicron fears